TheJobsMapAbout EVQLV
EVQLV develops artificial intelligence, engineered with life science data, to accelerate how biologic therapies reach patients. They work with partners at the discovery stage to accelerate the speed of antibody discovery.
Founded in 2019 by Andrew Satz and Brett Averso.
- Founded
- 2019
- Employees
- 1 to 10
- Total funding
- $60K
- Headquarters
- New York
Leadership
The top of EVQLV's org chart, with how many people report into each leader.
AS
Andrew Satz
Co-Founder & CEO
6 reports
RF
Richard Fox
Chief Scientific Officer
2 reports
BM
Ben Maida
Chief Commercial Officer
AS
Alexander Sonneborn
Operations & Analytics Consultant
BA
Brett Averso
CTO & Co-Founder
Board
RD
Roland Dunbrack
Advisor
SS
Simeon Simeonov
Advisor
BS
Boris Shor
Advisor
KM
Ken Moch
Advisor
VG
Vikas Goyal
Advisor
RL
Ron Lennox
Advisor
Jobs at EVQLV
No open positions right now. Explore more companies on TheJobsMap.